Part 11 Gap Analysis & Remediation Plan

Part 11 Gap Analysis and Remediation. The organization shall conduct a documented gap analysis for each system within the scope of 21 CFR Part 11 to identify any deficiencies between the current state of the system and the requirements of the regulation. The gap analysis shall systematically evaluate compliance with each applicable subsection of Part 11, including §11.10(a) through (k), §11.30 (if applicable), §11.50, §11.70, §11.100, §11.200, and §11.300. For each identified gap, the analysis shall document: (a) the specific regulatory requirement that is not met or is only partially met; (b) a description of the current state of the system with respect to that requirement; (c) a risk assessment evaluating the potential impact of the gap on product quality, patient safety, and data integrity; (d) the proposed remediation action, including whether the gap will be addressed through system configuration, procedural controls, technical upgrades, or acceptance of residual risk with documented justification; (e) the responsible party for implementing the remediation; (f) the target completion date; and (g) the verification method to confirm that the remediation has been effective. The gap analysis shall be prioritized based on risk, with critical gaps (those posing a direct risk to data integrity or patient safety) addressed first. Progress against the remediation plan shall be reported to senior management on a quarterly basis. The gap analysis shall be repeated periodically, at least every three (3) years, or whenever significant regulatory guidance is issued or system changes occur.